General Information
Version
3.0
Revision date
2024-10-25
Product name
Mixture
Icons in SDS
Company Information
company name
The Industrial Maintenance Group
e-mail address of the competent person responsible for the Safety Data Sheet
sales@img-limited.co.uk
GHS Information
Signal word
GHS05
Hazard Codes
Hazard statements (CLP)
H318
Hazard statements
Code
Statements
H318
Causes serious eye damage
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
and environmental serious eye damage. effects Causes serious eye damage. 2.2. Label elements Labelling according to Regulation (EC) No. 1272/2008 [CLP] Labelling according to Regulation (EC) Hazard No. 1272/2008 pictograms [CLP] (CLP) : Hazard pictograms (CLP) : GHS05 Signal word (CLP) GHS05
Adverse physicochemical, human health and environmental effects
Adverse physicochemical, human health Causes and environmental serious eye damage effects Causes serious eye damage
Hazard pictograms
[CLP] (CLP) GHS05
Signal word
GHS05 Danger
Hazard statements
Danger H318 - Causes serious eye damage.
Precautionary statements
H318 - Causes serious eye damage. P101 - If medical advice is needed, have product container or label at hand. P101 - If medical advice is needed, have product container or label at hand. P102 - Keep out of reach of children. P280 - Wear eye protection, protective clothing, protective gloves. P305+P351+P338+P310 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER or doctor.
Additional information
POISON CENTER or doctor. Contains 5-<15% non-ionic surfactants; <5% EDTA and salts thereof; perfumes; Contains 5-<15% non-ionic surfactants; <5% EDTA and salts thereof; perfumes; COUMARIN. 10/25/2024 (Revision date) GB - en 1/9 10/25/2024 (Revision date) GB - en Revision: 3.0 1/9
2.3 Other hazards
Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %